Home > Journals > Minerva Gastroenterologica e Dietologica > Past Issues > Minerva Gastroenterologica e Dietologica 2006 September;52(3) > Minerva Gastroenterologica e Dietologica 2006 September;52(3):293-301

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Gastroenterologica e Dietologica 2006 September;52(3):293-301

Copyright © 2006 EDIZIONI MINERVA MEDICA

language: English, Italian

The therapeutic role of thalidomide in inflammatory bowel disease

Casella G., De Marco E., Monti C., Baldini V.

1 Department of Medicine Desio Hospital, Desio, Milan, Italy 2 Department of Medicine Polyclinic of Monza, Monza, Milan, Italy


PDF


Recent clinical experience with the use of thalidomide in inflammatory bowel disease is the focus of this article. Although widely used in Crohn’s disease, thalidomide therapy in patients with ulcerative colitis, children with Crohn’s disease, as well as patients with Crohn’s disease associated with upper gastrointestinal and genital tract involvement have been occasionally reported.

top of page